ArticleMolecular psychiatry2022

Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies.

Mehdi Farokhnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.